tiprankstipranks
Corcept Therapeutics (CORT)
NASDAQ:CORT
CORT
Corcept Therapeutics
RESEARCH TOOLSreports
Want to see CORT full AI Analyst Report?

Corcept Therapeutics (CORT) Revenue

1,309 Followers
StatisticsMarket CapRevenue

Corcept Therapeutics Revenue

Corcept Therapeutics had a revenue of 164.90M in the quarter ending Mar 31, 2026, with -18.42%. This bring the company's revenue in the last twelve months to 769.10M, Decreased 1.01%. In the fiscal year ending Dec 31, 2025, Corcept Therapeutics had annual revenue of 761.41M with 12.79% growth.
Revenue (ttm)
769.10M
Revenue Growth
12.20%
P/S Ratio
10.56
Revenue/Employee
$1,522,814
Employees
500
Market Cap
$8.04B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
761.41M86.37M+12.79%
Dec 31, 2024
675.04M192.66M+39.94%
Dec 31, 2023
482.38M80.52M+20.04%
Dec 31, 2022
401.86M35.88M+9.80%
Dec 31, 2021
365.98M12.10M+3.42%
Dec 31, 2020
353.87M47.39M+15.46%
Dec 31, 2019
306.49M55.24M+21.99%
Dec 31, 2018
251.25M92.05M+57.82%
Dec 31, 2017
159.20M――